[{"Assets_0_Q2_USD":2621659000.0,"CommonStockSharesOutstanding_0_Q2_shares":48391071.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-17421000.0,"NetIncomeLoss_1_Q2_USD":-29215000.0,"NetIncomeLoss_2_Q2_USD":-44064000.0,"StockholdersEquity_0_Q2_USD":1483328000.0,"EarningsPerShareBasic_1_Q2_USD":-0.6,"EarningsPerShareBasic_2_Q2_USD":-0.91,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":48295000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":48342000.0,"Ticker":"LIVN","CIK":"1639691","name":"LIVANOVA PLC","OfficialName":"LivaNova PLC Ordinary Shares","form":"10-Q","period":"20190630","fy":"2019.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"4559360993.0","Country":"United Kingdom","Sector":"Health Care","Industry":"Biotechnology: Electromedical & Electrotherapeutic Apparatus","Market":"NASDAQ","SP500":"nan","filed":"20190731"}]